Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASAWASHINGTON (AP) — The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that's previously only been available with expensive, injectable drugs. The drug from Merck was OK'd on Thursday for patients with artery-clogging cholesterol that persists even after taking statins, the standard medications for cutting heart [...]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients | 5 | 7 | 18-07-2026 |
| 2 | What is the new FDA-approved pill designed to slash cholesterol levels? | 0 | 5 | 17-07-2026 |
| 3 | New PILL for psoriasis approved... giving hope to millions suffering from debilitating skin condition | 0 | 5.26 | 18-03-2026 |
| 4 | Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know | 5 | 7 | 01-07-2026 |
| 5 | Health Canada Approves Zepbound for OSA in Adults With Obesity | 5 | 8 | 25-06-2026 |
| 6 | Пресс-конференция о первом российском препарате от коронавируса. Видеотрансляция | 0 | 0 | 01-06-2020 |
| 7 | Three-in-one pill cuts heart failure hospitalizations by 60% | 7 | 7 | 04-07-2026 |
| 8 | Минздрав одобрил первую и единственную в России таблетированную форму препарата для лечения СМА | 5 | 7 | 06-07-2026 |
| 9 | Medicare now covering some GLP-1s for $50. Here's what to know | 5 | 7 | 02-07-2026 |
| 10 | Apnimed Appoints New CEO as Investigational OSA Therapy Nears FDA Decision | 0 | 5 | 22-06-2026 |